About apoQlar
apoQlar is a company based in Hamburg (Germany) founded in 2017. apoQlar has raised $10.85 million across 2 funding rounds from investors including YZR Capital and IFB Innovationsstarter. apoQlar offers products and services including HoloMedicine® Spaces, HoloMedicine® Robotics, 5G Solutions, Surgical Planning Software, and Medical Training Software. apoQlar operates in a competitive market with competitors including Fundamental Surgery, Oxford Medical Simulation, Osso VR, SimX and Surgical Science, among others.
- Headquarter Hamburg, Germany
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Apoqlar Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.85 M (USD)
in 2 rounds
-
Latest Funding Round
$10.85 M (USD), Series A
May 27, 2024
-
Investors
YZR Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of apoQlar
apoQlar offers a comprehensive portfolio of products and services, including HoloMedicine® Spaces, HoloMedicine® Robotics, 5G Solutions, Surgical Planning Software, and Medical Training Software.
Software for immersive 3D medical imaging and collaboration tools.
Platform for robotic surgical planning and remote operations.
Tools for 5G-enabled remote medical collaboration and training.
Application for 3D hologram imaging and pre-operative strategies.
VR simulations for medical student and professional training scenarios.
People of apoQlar
Unlock access to complete
Unlock access to complete
Funding Insights of apoQlar
apoQlar has successfully raised a total of $10.85M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10.85 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in apoQlar
apoQlar has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include YZR Capital and IFB Innovationsstarter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Support is provided for Hamburg's startups through grants and capital.
|
Locked | Locked | Locked | |
|
Healthtech sectors are supported via venture capital and acceleration.
|
Locked | Locked | Locked |
Investor details for apoQlar
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by apoQlar
Investment portfolio details for apoQlar
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - apoQlar
Detailed financials for apoQlar
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apoqlar Comparisons
Peer comparison for apoQlar
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of apoQlar
apoQlar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fundamental Surgery, Oxford Medical Simulation, Osso VR, SimX and Surgical Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based surgical simulation is enabled via VR and haptics.
|
|
| Locked | Locked | Locked |
VR-based medical training systems are developed for patient care simulations.
|
|
| Locked | Locked | Locked |
Virtual reality platform for surgical training is provided.
|
|
| Locked | Locked | Locked |
Provider of a VR-based medical simulation training platform
|
|
| Locked | Locked | Locked |
Medical simulation training products are provided for surgical procedures.
|
Detailed competitors of apoQlar
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apoqlar
Complete news archive for apoQlar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about apoQlar
apoQlar was founded in 2017 and raised its 1st funding round 6 years after it was founded.
apoQlar is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
apoQlar is a funded company, having raised a total of $10.85M across 2 funding rounds to date.
apoQlar was founded in 2017 in Hamburg, Germany, and operates in the medical technology sector. VR-based learning devices are supplied to surgeons, enabling the display of medical information including patient data, ultrasound images, microscope views, and endoscope screens as holograms on mixed reality glasses. These tools support surgical training and information visualization in clinical settings.
apoQlar's top competitors include Fundamental Surgery, SimX and Proximie.
apoQlar offers HoloMedicine® Spaces, HoloMedicine® Robotics, 5G Solutions, Surgical Planning Software, and Medical Training Software.
apoQlar has 2 investors. Key investors include YZR Capital, and IFB Innovationsstarter.